Skip to main content

Ultragenyx Pharmaceutical Inc 10-Q for FY2024 Q3

Ultragenyx Pharmaceutical Inc. (RARE)

10-Q 2024-11-06 For: 2024-09-30
View Original
Added on April 09, 2026

About this 10-Q

Ultragenyx Pharmaceutical Inc filed this 10-Q on November 6, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$139.49M
up 42.3% from $98.05M a year earlier
Net loss
$133.52M
compared with a net loss of $159.65M a year earlier
Diluted EPS
-$1.40
compared with -$2.23 a year earlier